These results complement and are generally consistent with those in previous studies using electrophoretic mobility shift assay (EMSA), showing that as compared with WT RUNX1, leukemia-causing RUNX1 mutants have a significantly reduced binding affinity to DNA. Here, RUNX1 is linked to leukemia.